Skin & Collagen Peptides

Skin signaling

Skin structure depends on extracellular matrix, hydration, barrier function and many cellular signals. A laboratory effect on collagen-related signaling is only an early step toward proving a visible clinical benefit.

GHK-Cu

GHK-Cu is a copper-binding tripeptide investigated in skin and wound-related research. Topical cosmetic preparations and injectable products have different exposure and safety questions. Their claims require separate evaluation.

Human trial example

A randomized study after carbon dioxide laser resurfacing examined a topical copper tripeptide regimen. Its small, procedure-specific context limits generalization to broad rejuvenation claims or different preparations.

Evidence quality

Small studies, different formulations and subjective cosmetic endpoints make comparisons difficult. A convincing claim needs a defined product, an appropriate comparator and reproducible outcomes across patients.

Topical use and procedures

A skin-care consultation can consider barrier health, irritation and existing treatment. Application after a procedure or through microneedling changes exposure. A cosmetic label does not establish suitability for those uses.

Safety limits

Irritation or sensitivity can occur with skin products. FDA highlights uncertainties for injectable GHK-Cu. REVIVE makes no claim that copper peptide injection is an established rejuvenation treatment.

Regulatory context in Egypt

Authorization belongs to an exact medicine, formulation, route and indication. Egyptian registration and the clinical governance of any future REVIVE service must be verified individually. A reference to overseas research or authorization does not establish local availability.

Frequently asked questions